Pancreatic Cancer Research

ResearcherHeriot-Watt UniversityActive in the last 2 years

Sally A. Peyman

Matched on ORCID iD 0000-0002-1600-5100; OpenAlex author ID A5048120892.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
1
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Effect of microbubble-assisted gemcitabine delivery with repeated ultrasound exposure in a pancreatic cancer organ-on-a-chip model. Last author DOI 10.1038/s41598-025-30612-2↗
  2. Modelling and breaking down the biophysical barriers to drug delivery in pancreatic cancer. Last author DOI 10.1039/d3lc00660c↗
  3. Modeling the mechanical stiffness of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.mbplus.2022.100109↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Delanyo Kpeglo · 3 shared papers, 2022–2025

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.